Literature DB >> 30611664

Review: Pathology and Its Clinical Relevance of Mucinous Appendiceal Neoplasms and Pseudomyxoma Peritonei.

Laura M Legué1, Geert-Jan Creemers2, Ignace H J T de Hingh3, Valery E P P Lemmens4, Clément J Huysentruyt5.   

Abstract

Until recently, many classifications existed for the terminology and histopathologic classification of appendiceal mucinous neoplasms, mucinous appendiceal adenocarcinomas, and pseudomyxoma peritonei (PMP). A major accomplishment was achieved by consensus-based histopathologic classifications on behalf of the Peritoneal Surface Oncology Group International regarding mucinous appendiceal tumours and PMP. As different classifications were used over the years and also owing to the rare nature of these tumors, many clinicians are not familiar with the terminology and the impact on patient management. Hence, an overview concerning mucinous appendiceal neoplasms, mucinous appendiceal adenocarcinomas, and PMP is provided to serve as an introduction into the basic morphology of these tumors with tentative recommendations for management.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HAMN; LAMN; Management; Mucinous appendiceal adenocarcinoma; Pseudomyxoma peritonei (PMP)

Mesh:

Year:  2018        PMID: 30611664     DOI: 10.1016/j.clcc.2018.11.007

Source DB:  PubMed          Journal:  Clin Colorectal Cancer        ISSN: 1533-0028            Impact factor:   4.481


  2 in total

1.  A rare cecal subepithelial tumor in a Crohn´s Disease patient.

Authors:  Joana Inês Alves da Silva; Cidalina Caetano; Anabela Maria Sousa da Rocha; Nuno Jorge Lamas; Paula Lago; Isabel Maria Teixeira de Carvalho Pedroto
Journal:  Autops Case Rep       Date:  2020-12-08

2.  Unusual site of pseudomyxoma peritonei recurrence after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a case report of intraluminal disease manifestation in the small bowel.

Authors:  Paulien Rauwerdink; Lodewijk A A Brosens; Karin K van Diepen; Okan N Ghedri; Onno Kranenburg; Djamila Boerma; Arjen J Witkamp; Helma M U van Grevenstein
Journal:  World J Surg Oncol       Date:  2022-05-10       Impact factor: 3.253

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.